This excerpt taken from the ABII 8-K filed Feb 9, 2009.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ABRAXIS BIOSCIENCE, INC.
By:
/s/ David OToole
David OToole
Executive Vice President and Chief Financial Officer